Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow

ConclusionDiagnostics and treatment of newly diagnosed and relapsed MM are continuously evolving. While advances in the field of (single cell) genetic analysis now allow for characterization of the disease at an unprecedented resolution, immunotherapeutic approaches and MRD testing are at the forefront of the current clinical trial landscape.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research